Close
Show
Home Research Insight

Research Insight

This unique section brings insights into latest break-through in Pharma Research, laboratory investigations, studies and results of clinical trials. These insights from senior professionals in R&D laboratories, Institutes would help the Pharma Professionals develop refined perspective on the trends in the Pharma Market and the issues concerning the domain.

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities...

Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel...

Eisai Co., Ltd  and University College London   announced  that they have commenced preparations for Phase I clinical studies on E2814 The...

ADC Bio secures additional equity round investment

ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment...

Protagen AG collaborates with UCSF to study better immuno-profiling of cancer patients receiving immunotherapy

Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate...

The Falsified Medicines Directive – are you ready?

The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require pharmaceuticalcompanies to apply serialisation codes to every applicable pack...

Stem Cell and Regenerative Therapies for Hearing Loss

The year 2018 marks a notable milestone in the history of stem cell and regenerative medicine. It was twenty years ago, in 1998, that...

High quality ophthalmic consumables at affordable prices to developing countries: An Aurolabs Case Study

Aurolab, the manufacturing division of Aravind Eye Hospital, at Madurai, Tamil Nadu that supplies high quality ophthalmic consumables at affordable prices to developing countries. Though...

Organovo Receives Orphan Designation From U.S. FDA for 3D Bioprinted Therapeutic Liver Tissue Treatment...

Organovo Holdings, Inc announced that the U.S. FDA granted orphan drug designation for the Company’s treatment of alpha-1 antitrypsin deficiency (“A1AT”) with its 3D...

Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy

Promoting interdisciplinary exchange between science and industry on the topics of regenerative medicine and cell therapy: this is the objective Sartorius will be pursuing...

Mount Sinai Researchers Identify Novel Therapeutic Targets for Metastatic Melanoma, Path for New Drugs

Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study published in Molecular Cell. The study...